Anne Lindblad Quanbeck

Quanbeck, a biostatistician with more than 38 years of experience serving both industry and government clients, is the president and CEO of Emmes, a global contract research organization. She has supported clinical research throughout her career, serving as principal investigator of projects spanning diverse disease areas, including oncology, dialysis, transplantation, ophthalmology, speech and hearing, dentistry, and neurology. She has contributed to the literature in such fields as patient-reported outcome development, central statistical monitoring as part of a risk-based monitoring plan, disease classification systems, and barriers to recruiting for clinical trials.

After completing her B.S. degree in statistics at Hollins, Quanbeck went on to earn a Master’s degree in biostatistics from the Medical College of Virginia/Virginia Commonwealth University, and a Ph.D. in statistics from George Washington University.